BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2106 related articles for article (PubMed ID: 30376188)

  • 21. Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.
    Dennett EJ; Janjua S; Stovold E; Harrison SL; McDonnell MJ; Holland AE
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013384. PubMed ID: 34309831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interventions for the prevention of recurrent erysipelas and cellulitis.
    Dalal A; Eskin-Schwartz M; Mimouni D; Ray S; Days W; Hodak E; Leibovici L; Paul M
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD009758. PubMed ID: 28631307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Digital interventions for the management of chronic obstructive pulmonary disease.
    Janjua S; Banchoff E; Threapleton CJ; Prigmore S; Fletcher J; Disler RT
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013246. PubMed ID: 33871065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled corticosteroids versus placebo  for stable chronic obstructive pulmonary disease.
    Yang IA; Ferry OR; Clarke MS; Sim EH; Fong KM
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD002991. PubMed ID: 36971693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).
    Janjua S; Carter D; Threapleton CJ; Prigmore S; Disler RT
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013196. PubMed ID: 34693988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease.
    Ni H; Aye SZ; Naing C
    Cochrane Database Syst Rev; 2022 May; 5(5):CD013506. PubMed ID: 35616126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Macrolides versus placebo for chronic asthma.
    Undela K; Goldsmith L; Kew KM; Ferrara G
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD002997. PubMed ID: 34807989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).
    Janjua S; Pike KC; Carr R; Coles A; Fortescue R; Batavia M
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013381. PubMed ID: 34496032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease.
    Poole P; Sathananthan K; Fortescue R
    Cochrane Database Syst Rev; 2019 May; 5(5):CD001287. PubMed ID: 31107966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
    Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statins versus placebo for people with chronic obstructive pulmonary disease.
    Walsh A; Perrem L; Khashan AS; Henry MT; Ni Chroinin M
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011959. PubMed ID: 31425628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tiotropium versus placebo for chronic obstructive pulmonary disease.
    Karner C; Chong J; Poole P
    Cochrane Database Syst Rev; 2014 Jul; 2014(7):CD009285. PubMed ID: 25046211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.
    Chong J; Karner C; Poole P
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD009157. PubMed ID: 22972134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009552. PubMed ID: 26391969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
    Smith S; Rowbotham NJ
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009552. PubMed ID: 24043433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic and topical antibiotics for chronic rhinosinusitis.
    Head K; Chong LY; Piromchai P; Hopkins C; Philpott C; Schilder AG; Burton MJ
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD011994. PubMed ID: 27113482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotics for preventing lower respiratory tract infections in high-risk children aged 12 years and under.
    Onakpoya IJ; Hayward G; Heneghan CJ
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011530. PubMed ID: 26408070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adverse events in people taking macrolide antibiotics versus placebo for any indication.
    Hansen MP; Scott AM; McCullough A; Thorning S; Aronson JK; Beller EM; Glasziou PP; Hoffmann TC; Clark J; Del Mar CB
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD011825. PubMed ID: 30656650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors for chronic obstructive pulmonary disease.
    Kikuchi S; Imai H; Tani Y; Tajiri T; Watanabe N
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013113. PubMed ID: 32844430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 106.